4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0000905148-24-003242
EVP, CFO and COO sold 1,364 shares at $11.20 ($15,274)
From the SEC's structured data for this filing
Trades in this filing
Hyllengren Eric J · EVP, CFO and COO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-18 | Sale : show line 1 in the form | −1,364 | $11.20 | $15,274 | 23,392 | D |
| Open-market sales · 1,364 sh · avg $11.20 · $15,274 | ||||||
Loading xslF345X05/form4.xml…